Alipour, A., Farhadi, P., Mobaraki, K., Mardaneh, P., Mohammadi, S., Khoshneviszadeh, M., Pirhadi, S., Poustforoosh, A., Saso, L., Edraki, N., Firuzi, O., Spiroisatin pyranopyrimide derivatives as receptor tyrosine kinase inhibitors and targeted anticancer agents. Jun 2025
Eskandari, M., Moosavi, F., Nazari, S., Mardaneh, P., Poustforoosh, A., Zargari, F., Mohabbati, M., Saso, L., Edraki, N., Firuzi, O,. N-ethyl morpholine-deca hydroacridine 1, 8-diones as novel P-gp inhibitors and multidrug resistance reversal agents in cancer cells. Mar 2025
Eskandari, M., Moosavi, F., Nazari, S., Mardaneh, P., Poustforoosh, A., Zargari, F., Mohabbati, M., Saso, L., Edraki, N., Firuzi, O., N-ethyl morpholine-deca hydroacridine 1, 8-diones as novel P-gp inhibitors and multidrug resistance reversal agents in cancer cells. Mar 2025
Emami, L., Hoshyar, S., Bina, S., Zare, F., Mardaneh, P., Haghshenas, M., Poustforoosh, A., Firouzabadi, N., Rashedinia, M,. Binding interaction of food preservatives with glycosylated DNA: In vitro assessment and computational studies. Mar 2025
Akkus, M., Kirici, M., Poustforoosh, A., Erdogan, M., Gundogdu, R., Tüzün, B., Taslimi, P., Phenolic Compounds: Investigating Their Anti-Carbonic Anhydrase, Anti-Cholinesterase, Anticancer, Anticholinergic, and Antiepileptic Properties Through Molecular Docking, MM-GBSA, and Dynamics Analyses. 2025
Poustforoosh, A., Optimizing kinase and PARP inhibitor combinations through machine learning and in silico approaches for targeted brain cancer therapy. 2025
Nazari, S., Poustforoosh, A., Paul, P., Kukreti, R., Tavakkoli, M., Saso, L., Firuzi, O., Moosavi, F., c-MET tyrosine kinase inhibitors reverse drug resistance mediated by the ATP-binding cassette transporter B1 (ABCB1) in cancer cells. Jun 2025
Ataollahi, E., Emami, L., Mohammad Al-Dies, A., Zare, f., Poustforoosh, A., Emami, M., Saadat, F., Motamen, F., Rezaei, Z., Khabnadideh, S., Design, synthesis, in silico studies and antiproliferative evaluation of some novel hybrids of pyrimidine-morpholine. Feb 2025
Mohammadi, S., Mortazavia, M., Poustforoosh, A., Moosavi, F., Saso, L., Edraki, N., Firuzi, O., Novel spiroisatin-pyranopyrazole hybrids as anticancer agents with TrkC inhibitory potential. 2025
Moosavi, F., Divar, M., Khabnadideh, S., Tavakkoli, M., Mohabbati, M., Saso, L., Poustforoosh, A., Firuzi, O., Spiroindoline quinazolinedione derivatives as inhibitors of P-glycoprotein: potential agents for overcoming multidrug resistance in cancer therapy. 2025
Poustforoosh A*. Investigation on the structural and dynamical properties of Cationic, Anionic, and Catanionic niosomes as multifunctional controlled drug delivery system for Cabozantinib “Colloids and Surfaces A: Physicochemical and Engineering Aspects” 2024. (* Corresponding author)
Poustforoosh A, Faramarz S, Nematollahi MH, Mahmoodi M, Azadpour M.Structure-Based Drug Design for Targeting IRE1: An in Silico Approach for Treatment of Cancer.“Drug Research”2024.
Kırıcı M, Tüzün B, Kırıcı M, Atamanalp M, Poustforoosh A, Beydemir S, Reşit Taysı M. The impact of some metals, molecular docking and molecular dynamic calculations on glucose 6-phosphate dehydrogenase activity in Capoeta trutta (Heckel, 1843) tissue.“Journal of Molecular Liquids” 2024
Nazari S, Mosaffa F, Poustforoosh A, Mortazavi M, Saso L, Firuzi O, Moosavi F. Foretinib, a c-MET receptor tyrosine kinase inhibitor, tackles multidrug resistance in cancer cells by inhibiting ABCB1 and ABCG2 transporters.“Toxicology and Applied Pharmacology”. 2024
Firouzi M, Haghighijoo Z, Eskandari M, Mohabbati M, Miri R, Jamei MH, Poustforoosh A, Nazari S, Firuzi O, Khoshneviszadeh M, Edraki N. Synthesis and Cytotoxic Activity Evaluation of Novel Imidazopyridine Carbohydrazide Derivative. “BMC Chemistry”2024
Sadeghian S, Bekhradi F, Mansouri F, Razmi R, Mansouri G, Poustforoosh A, Khabnadideh S, Zomorodian K, Zareshahrabadi Z, Rezaei Z. Imidazole Derivatives as Novel and Potent Antifungal Agents: Synthesis, Biological Evaluation, Molecular Docking Study, Molecular Dynamic Simulation and ADME Prediction. “Journal of Molecular Structure” 2024.
Poustforoosh A*, Faramarz S, Negahdaripour M, Tüzün B, Hashemipour H. Investigation on themechanisms by which the herbal remedies induce anti-prostate cancer activity:uncovering the most practical natural compound.“Journal of Biomolecular Structure and Dynamics”2023. (* Corresponding author)
Poustforoosh A*, Faramarz S, Negahdaripour M, Tüzün B, Hashemipour H. Tracing the pathways and mechanisms involved in the anti-breast cancer activity of glycyrrhizin using bioinformatics tools and computational methods.“Journal of Biomolecular Structure and Dynamics”2023. (* Corresponding author)
Poustforoosh A*, Faramarz S, Negahdaripour M, Hashemipour. Modeling and affinity maturation of an anti-CD20 nanobody: a comprehensive in-silico investigation.“Scientific Reports” 2023. (* Corresponding author)
Poustforoosh A, F Moosavi. Evaluation of the FDA-approved kinase inhibitors to uncover the potential repurposing candidates targeting ABC transporters in multidrug-resistant cancer cells: An in silico approach.“Journal of Biomolecular Structure and Dynamics”2023.
Taysi MR, Kirici M, Kirici M, Tuzun B, Poustforoosh A. Antioxidant enzyme activities, molecular docking studies, MM-GBSA, and molecular dynamic of chlorpyrifos in freshwater fish Capoeta umbla.“Journal of Biomolecular Structure and Dynamics”2023.
Rashedinia M, Rasti Arbabi Z, Sabet R, Emami L, Poustforoosh A, Sabahi Z. Comparison of protective effects of phenolic acids on protein glycation of BSA supported by in vitro and docking study.“Biochemistry Research International”2023.
Fazel R, Hassani B, Zare F, Jokar Darzi H, Khoshneviszadeh M, Poustforoosh A; Behrouz M; Sadeghpour H, R Sabet. Design, Synthesis, in silico ADME, DFT, Molecular Dynamics Simulation, Anti-Tyrosinase, and Antioxidant Activity of Some of the 3-Hydroxypyridin- 4-one Hybrids in Combination with Acylhydrazone Derivatives.“Journal of Biomolecular Structure and Dynamics”2023
Moheimanian N, Mirkhani H, Edraki N, Poustforoosh A, Momeni S, Khalighian N, Zidorn C), Jassbi AR. Bioassay-guided purification of α-glucosidase inhibitor fatty acids from Padina tetrastromatica.“Journal of Applied Phycology” 2023
Poustforoosh A, Faramarz S, Nematollahi MH, Hashemipour H, Pardakhty A. Construction of Bio-conjugated nano-vesicles using non-ionic surfactants for targeted drug delivery: A computational supported experimental study.“Journal of Molecular Liquids”2022
Poustforoosh A*, Faramarz S, Nematollahi MH, Hashemipour H, Negahdaripour M, Pardakhty A. In silico SELEX screening and statistical analysis of newly designed 5mer peptide-aptamers as Bcl-xl inhibitors using the Taguchi method.“Computers in Biology and Medicine”2022. (* Corresponding author)
Poustforoosh A, Nematollahi MH, Hashemipour H, Pardakhty A. Recent advances in Bio-conjugated nanocarriers for crossing the Blood-Brain Barrier in (pre-) clinical studies with an emphasis on vesicles.“Journal of Controlled Release”2022
Poustforoosh A, Faramarz S, Nematollahi MH, Hashemipour H, Tüzün B, Pardakhty A, Mehrabani M. 3D-QSAR, molecular docking, molecular dynamics, and ADME/T analysis of marketed and newly designed flavonoids as inhibitors of Bcl-2 family proteins for targeting U-87 glioblastoma.“Journal of Cellular Biochemistry”2022
Poustforoosh A, Hashemipour H, Tüzün B, Azadpour M, Faramarz S, Pardakhty A, Mehrabani M, Nematollahi MH. The Impact of D614G Mutation of SARS-COV-2 on the Efficacy of Anti-viral Drugs: A Comparative Molecular Docking and Molecular Dynamics.“Current Microbiology”2022
Abdollahdokht D, Gao Y, Faramarz S, Poustforoosh A, Abbasi M, Asadikaram G, Nematollahi MH. Conventional agrochemicals towards nano-biopesticides: an overview on recent advances. 2022
Naghiyev F, Mamedov I, Askerov R, Taslimi P, Poustforoosh A*. Synthesis and Biological Activity of Functionally Substituted Pyrimidine and Pyran Derivatives on the Basis of Isatylidene Malononitriles. 2022. (* Corresponding author)
Poustforoosh A, Hashemipour H, Tüzün B, Pardakhty A, Mehrabani M, Nematollahi MH. Evaluation of potential anti-RNA-dependent RNA polymerase (RdRP) drugs against the newly emerged model of COVID-19 RdRP using computational methods. “Biophysical Chemistry”2021
Poustforoosh A, Hashemipour H, Pardakhty A, Kalantari pour M. Preparation of nano-micelles of meloxicam for transdermal drug delivery and simulation of drug release:A computational supported experimental study.“The Canadian Journal of Chemical Engineering”2021
Asadikaram G, Poustforoosh A, Pardakhty A, Torkzade Mahani M, Nematollahi MH. Niosomal Virosome derived by vesicular stomatitis virus glycoprotein as a new gene carrier. “Biochemical and Biophysical Research Communications”2021
Mehrabani M, Raeiszadeh M, Najafipour H, Esmaeli Tarzi M, Amirkhosravi A, Poustforoosh A, Mohammadi M, Naghdi S, Mehrabani M. Evaluation of the Cytotoxicity, Antibacterial, Antioxidant, and Anti-inflammatory Effects of Different Extracts of Punica granatum var. pleniflora. “Journal of Kerman University of Medical Sciences” 2020
